Humana Inc.
General ticker "HUM" information:
- Sector: Health Care
- Industry: Medical - Healthcare Plans
- Capitalization: $29.3B (TTM average)
Humana Inc. follows the US Stock Market performance with the rate: 37.8%.
Estimated limits based on current volatility of 2.6%: low 370.02$, high 389.75$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-06-26, amount 0.89$ (Y0.95%)
- Total employees count: 67060 (+2.1%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Regulatory and compliance, Medical cost inflation, Cybersecurity threats, Litigation risks, Acquisition/divestiture risks
- Current price 13.0% above estimated high
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [219.46$, 329.83$]
- 2026-12-31 to 2027-12-31 estimated range: [241.96$, 357.94$]
Financial Metrics affecting the HUM estimates:
- Negative: with PPE of 15.1 at the end of fiscal year the price was high
- Positive: -4.17 < Operating profit margin, % of 2.09
- Negative: 0.75 < Interest expense per share per price, % of 2.03
- Negative: 19.10 < Shareholder equity ratio, % of 36.10 <= 42.34
- Positive: 0 < Industry operating cash flow per share per price (median), % of 3.62
- Positive: Investing cash flow per share per price, % of 7.31 > -0.65
- Positive: Industry inventory ratio change (median), % of 0.22 <= 0.27
- Positive: Inventory ratio change, % of -0.05 <= 0
- Positive: 1.89 < Return on assets ratio (scaled to [-100,100]) of 2.60
Short-term HUM quotes
Long-term HUM plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $106,374.00MM | $117,761.00MM | $129,664.00MM |
| Operating Expenses | $102,361.00MM | $115,199.00MM | $126,960.00MM |
| Operating Income | $4,013.00MM | $2,562.00MM | $2,704.00MM |
| Non-Operating Income | $-630.00MM | $-841.00MM | $-1,149.00MM |
| Interest Expense | $493.00MM | $660.00MM | $631.00MM |
| Income(Loss) | $3,383.00MM | $1,721.00MM | $1,555.00MM |
| Taxes | $836.00MM | $413.00MM | $250.00MM |
| Other Income(Loss) | $-63.00MM | $-94.00MM | $-102.00MM |
| Net Income(Loss)* | $2,489.00MM | $1,207.00MM | $1,188.00MM |
| Stockholders Equity | $16,262.00MM | $16,375.00MM | $17,657.00MM |
| Assets | $47,065.00MM | $46,479.00MM | $48,909.00MM |
| Operating Cash Flow | $3,981.00MM | $2,966.00MM | $921.00MM |
| Capital expenditure | $1,004.00MM | $575.00MM | $546.00MM |
| Investing Cash Flow | $-3,492.00MM | $-2,952.00MM | $2,273.00MM |
| Financing Cash Flow | $-856.00MM | $-2,487.00MM | $-1,215.00MM |
| Earnings Per Share** | $20.09 | $10.01 | $9.86 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.